Suppr超能文献

激肽释放酶原的前清蛋白激活剂。II. 用纤溶酶消化活性Hageman因子以获得激肽释放酶原激活剂

A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.

作者信息

Kaplan A P, Austen K F

出版信息

J Exp Med. 1971 Apr 1;133(4):696-712. doi: 10.1084/jem.133.4.696.

Abstract

Activation of a plasma fraction containing unactivated Hageman factor and prekallikrein followed by chromatography of this fraction on DEAE-cellulose revealed four peaks having bradykinin-generating activity. Peak 1 contained kallikrein; peaks 2-3, 4, and 5 each contained prekallikrein-activating activity. Elution of peaks 2-3, 4, and 5 from disc gels after electrophoresis at pH 9.3 revealed peaks of prekallikrein-activating activity located at 5-8, 11-12, 15-16, and 20-26 mm, each of which was associated with a peak of clot-promoting activity which specifically corrected Hageman factor deficiency. Conversion of peak 2 to peaks 3, 4, and 5 was associated with a progressive decrease in size, increase in net negative charge, increased prekallikrein-activating activity, and decreased ability to correct Hageman factor deficiency. Plasminogen and plasmin were found on a DEAE-cellulose chromatogram of serum overlapping peaks 2 and 3. Incubation of active Hageman factor with streptokinase-activated plasminogen resulted in enhanced ability of the mixture to activate prekallikrein. Assessment of the products of this reaction by disc gel electrophoresis demonstrated the formation of the prealbumin prekallikrein activator corresponding to the major prekallikrein activator generated by contact activation of human plasma. The conversion of plasminogen to plasmin and the subsequent cleavage of Hageman factor by plasmin to form activators of prekallikrein represents one pathway in which coagulation, fibrinolysis, and inflammation are linked.

摘要

含有未活化的哈格曼因子和前激肽释放酶的血浆组分被激活后,将该组分在二乙氨基乙基纤维素上进行层析,结果显示有4个峰具有生成缓激肽的活性。峰1含有激肽释放酶;峰2 - 3、4和5各自含有前激肽释放酶激活活性。在pH 9.3条件下进行电泳后,从圆盘凝胶上洗脱峰2 - 3、4和5,结果显示前激肽释放酶激活活性峰位于5 - 8、11 - 12、15 - 16和20 - 26毫米处,每个峰都与一个促凝活性峰相关联,该促凝活性峰能特异性纠正哈格曼因子缺乏症。峰2向峰3、4和5的转变与大小逐渐减小、净负电荷增加、前激肽释放酶激活活性增加以及纠正哈格曼因子缺乏症的能力降低有关。在血清的二乙氨基乙基纤维素层析图上,发现纤溶酶原和纤溶酶与峰2和峰3重叠。活性哈格曼因子与链激酶激活的纤溶酶原一起孵育,导致混合物激活前激肽释放酶的能力增强。通过圆盘凝胶电泳对该反应产物进行评估,结果显示形成了与通过人血浆接触激活产生的主要前激肽释放酶激活剂相对应的前清蛋白前激肽释放酶激活剂。纤溶酶原向纤溶酶的转变以及随后纤溶酶对哈格曼因子的裂解以形成前激肽释放酶激活剂,代表了凝血、纤维蛋白溶解和炎症相联系的一条途径。

相似文献

引用本文的文献

9

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验